
Unmet Needs in Atopic Dermatitis and the Impact of Roflumilast Cream, with Raj Chovatiya, MD, PhD
Roflumilast is a therapeutic option for many patients with inflammatory conditions such as atopic dermatitis. It was approved by the US Food and Drug Administration (FDA) in 2024 as roflumilast cream 0.15% for individuals aged 6 years and older with …